Profiling of Anti‐FVIII Antibodies in Acquired Haemophilia A: ‘Insights into Domain Specificity, Isotype Variability, and Clinical Correlations’
Haemophilia · 2025
DOI: 10.1111/hae.70056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haemophilia, 2025. Verfasst von Ann-Cristin Berkemeier und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Hematology and Transfusion Medicine, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Hemophilia A, Factor VIII, Autoantibodies, Immunoglobulin Isotypes. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Octapharma Germany.
Abstract (Originalsprache)
Introduction
Acquired haemophilia A (AHA) is a rare autoimmune disorder caused by autoantibodies against coagulation factor VIII (FVIII), resulting in significant bleeding risks.
Aim
To characterize the anti‐FVIII antibody profile in AHA patients by assessing isotypes, subclasses, and correlations with key clinical parameters.
Methods
Eighty AHA patients were retrospectively analysed by assessing FVIII inhibitor levels, antibody isotypes (IgG, IgA, IgM), IgG subclasses, and domain specificity using a bead‐based assay. Clinical data were correlated with antibody profiles. IgG domain profiles were compared with a congenital haemophilia A (CHA) cohort.
Results
The cohort had a median age of 74 years, with 60% males. Idiopathic cases accounted for 67%, and 17% had bleeding linked to medical interventions. Major bleeding sites were musculoskeletal/retroperitoneal (45%) and skin (36%). Within six months, 18% of patients died, mostly from sepsis. Anti‐FVIII IgG antibodies were present in all patients, with IgG 4 (96%) and IgG 3 (60%) being the most common subclasses. IgM and IgA anti‐FVIII antibodies were detected in 17.5% and 18.8% of patients, respectively, with IgM positivity associated with higher mortality (33%). IgG 4 subclass correlated significantly with inhibitor titres ( r s = 0.54; p < 0.001). Compared to CHA, AHA showed a higher prevalence of C1C2 domain‐targeting antibodies (49% vs. 77%), associated with NBA levels ( r s = 0.51; p < 0.001).
Conclusion
Anti‐FVIII antibody profiling reveals distinct patterns in AHA, with IgG 4 linked to higher inhibitor levels. The C1C2 domain specificity of the anti‐FVIII antibodies suggests a potential role of this FVIII domain in the immunopathology of AHA patients, warranting further investigation to improve prognostic tools.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental Hematology and Transfusion Medicine, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
- Center for Rare Diseases Bonn (ZSEB), University Clinic Bonn, Bonn, Germany.
ORCID-Profile: Isabell Matuschek, Johannes Oldenburg, Behnaz Pezeshkpoor
Förderung
- Octapharma Germany
Zitieren
APA
Berkemeier, A. C., Matuschek, I., Hartlieb, K., Albert, T., Marquardt, N., Oldenburg, J., & Pezeshkpoor, B. (2025). Profiling of Anti‐FVIII Antibodies in Acquired Haemophilia A: ‘Insights into Domain Specificity, Isotype Variability, and Clinical Correlations’. Haemophilia. https://doi.org/10.1111/hae.70056
Vancouver
Berkemeier AC, Matuschek I, Hartlieb K, Albert T, Marquardt N, Oldenburg J, et al. Profiling of Anti‐FVIII Antibodies in Acquired Haemophilia A: ‘Insights into Domain Specificity, Isotype Variability, and Clinical Correlations’. Haemophilia. 2025. doi:10.1111/hae.70056
BibTeX
@article{Berkemeier2025,
author = {Berkemeier, Ann-Cristin and Matuschek, Isabell and Hartlieb, Katrin and Albert, Thilo and Marquardt, Natascha and Oldenburg, Johannes and Pezeshkpoor, Behnaz},
title = {Profiling of Anti‐FVIII Antibodies in Acquired Haemophilia A: ‘Insights into Domain Specificity, Isotype Variability, and Clinical Correlations’},
journal = {Haemophilia},
year = {2025},
doi = {10.1111/hae.70056}
}
EUVIMED